| Treatment of high-grade non–muscle-invasive bladder carcinoma by standard number and dose of BCG instillations versus reduced number and standard dose of BCG instillations … MO Grimm, AG van der Heijden, M Colombel, T Muilwijk, ... European urology 78 (5), 690-698, 2020 | 106 | 2020 |
| Quality control indicators for transurethral resection of non–muscle-invasive bladder cancer M Akand, T Muilwijk, Y Raskin, M De Vrieze, S Joniau, F Van Der Aa Clinical genitourinary cancer 17 (4), e784-e792, 2019 | 57 | 2019 |
| The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer–a multicentre observational study S Khadhouri, KM Gallagher, KR MacKenzie, TT Shah, C Gao, S Moore, ... BJU international 128 (4), 440-450, 2021 | 45 | 2021 |
| Efficacy of preoperative chemotherapy for high risk upper tract urothelial carcinoma B Foerster, M Abufaraj, F Petros, M Azizi, M Gupta, D Schweitzer, ... The Journal of urology 203 (6), 1101-1108, 2020 | 44 | 2020 |
| Diagnostic value of 18F-fluorodeoxyglucose positron emission tomography with computed tomography for lymph node staging in patients with upper tract urothelial carcinoma CS Voskuilen, D Schweitzer, JB Jensen, AM Nielsen, S Joniau, T Muilwijk, ... European urology oncology 3 (1), 73-79, 2020 | 40 | 2020 |
| Pretreatment risk stratification for endoscopic kidney-sparing surgery in upper tract urothelial carcinoma: an international collaborative study B Foerster, M Abufaraj, SF Matin, M Azizi, M Gupta, WM Li, T Seisen, ... European urology 80 (4), 507-515, 2021 | 36 | 2021 |
| Impact of neoadjuvant chemotherapy on short-term complications and survival following radical cystectomy U Milenkovic, M Akand, L Moris, L Demaegd, T Muilwijk, Y Bekhuis, ... World Journal of Urology 37, 1857-1866, 2019 | 30 | 2019 |
| Comparison of postoperative complications of ileal conduits versus orthotopic neobladders L Demaegd, M Albersen, T Muilwijk, U Milenkovic, L Moris, W Everaerts, ... Translational Andrology and Urology 9 (6), 2541, 2020 | 24 | 2020 |
| Which patients with clinically node-positive prostate cancer should be considered for radical prostatectomy as part of multimodal treatment? The impact of nodal burden on long … G Gandaglia, M Soligo, A Battaglia, T Muilwijk, D Robesti, E Mazzone, ... European urology 75 (5), 817-825, 2019 | 24 | 2019 |
| External validation of Memorial Sloan Kettering Cancer Center nomogram and prediction of optimal candidate for lymph node dissection in clinically localized prostate cancer D Milonas, Z Venclovas, T Muilwijk, M Jievaltas, S Joniau Central European Journal of Urology 73 (1), 19, 2020 | 23 | 2020 |
| When residents work less, they feel better: Lessons learned from an unprecedent context of lockdown A Degraeve, S Lejeune, T Muilwijk, F Poelaert, M Piraprez, I Svistakov, ... Progrès en urologie 30 (16), 1060-1066, 2020 | 20 | 2020 |
| Developing a diagnostic multivariable prediction model for urinary tract cancer in patients referred with haematuria: results from the IDENTIFY collaborative study S Khadhouri, KM Gallagher, KR MacKenzie, TT Shah, C Gao, S Moore, ... European Urology Focus 8 (6), 1673-1682, 2022 | 17 | 2022 |
| Novel classification for upper tract urothelial carcinoma to better risk-stratify patients eligible for kidney-sparing strategies: an international collaborative study G Marcq, B Foerster, M Abufaraj, SF Matin, M Azizi, M Gupta, WM Li, ... European Urology Focus 8 (2), 491-497, 2022 | 17 | 2022 |
| Stromal marker fibroblast activation protein drives outcome in T1 non-muscle invasive bladder cancer T Muilwijk, M Akand, S Daelemans, K Marien, Y Waumans, M Kockx, ... PLoS One 16 (9), e0257195, 2021 | 14 | 2021 |
| The potential of tumour microenvironment markers to stratify the risk of recurrence in prostate cancer patients T Gevaert, YR Van Eycke, T Vanden Broeck, H Van Poppel, I Salmon, ... PLoS One 15 (12), e0244663, 2020 | 14 | 2020 |
| Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high–grade non-muscle-invasive urothelial bladder cancer W Krajewski, J Aumatell, JD Subiela, Ł Nowak, A Tukiendorf, M Moschini, ... Urologic Oncology: Seminars and Original Investigations 40 (11), 491. e11 …, 2022 | 13 | 2022 |
| Head-to-head comparison of two nomograms predicting probability of lymph node invasion in prostate cancer and the therapeutic impact of higher nomogram threshold Z Venclovas, T Muilwijk, AJ Matjosaitis, M Jievaltas, S Joniau, D Milonas Journal of Clinical Medicine 10 (5), 999, 2021 | 13 | 2021 |
| Testicular cancer MP Laguna, P Albers, F Algaba, C Bokemeyer, JL Boormans, S Fischer, ... EAU Annual Congress Amsterdam, 2020 | 13 | 2020 |
| Comparison of peri-operative and early oncological outcomes of robot-assisted vs. open salvage lymph node dissection in recurrent prostate cancer G Devos, T Muilwijk, Y Raskin, V Calderon, L Moris, T Van den Broeck, ... Frontiers in Oncology 9, 781, 2019 | 13 | 2019 |
| Metastasectomy of oligometastatic urothelial cancer: a single-center experience T Muilwijk, M Akand, F Van der Aa, H Dumez, G De Meerleer, ... Translational Andrology and Urology 9 (3), 1296, 2020 | 12 | 2020 |
